{"id":"https://openalex.org/W2019277993","doi":"https://doi.org/10.1161/01.cir.73.2.240","title":"Therapeutic opportunities in vasoocclusive disease.","display_name":"Therapeutic opportunities in vasoocclusive disease.","publication_year":1986,"publication_date":"1986-02-01","ids":{"openalex":"https://openalex.org/W2019277993","doi":"https://doi.org/10.1161/01.cir.73.2.240","mag":"2019277993","pmid":"https://pubmed.ncbi.nlm.nih.gov/2935325"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.73.2.240","doi":"https://doi.org/10.1161/01.cir.73.2.240","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.cir.73.2.240","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.73.2.240","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.73.2.240","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108582954","display_name":"J M Ritter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M Ritter","raw_affiliation_strings":["J M Ritter"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"J M Ritter","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111876502","display_name":"C T Dollery","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C T Dollery","raw_affiliation_strings":["C T Dollery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"C T Dollery","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1833,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.27647059,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"2","first_page":"240","last_page":"243"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.2639000117778778,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.2639000117778778,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10926","display_name":"Peripheral Artery Disease Management","score":0.20340000092983246,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.19689999520778656,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9639999866485596},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.8360000252723694},{"id":"https://openalex.org/keywords/combination-antithrombotic-therapy","display_name":"combination antithrombotic therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/antiplatelet-drugs","display_name":"antiplatelet agents","score":0.6639999747276306},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9217215180397034},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.7436920404434204},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.7329087257385254},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6178720593452454},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5008411407470703},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4319304823875427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15251752734184265}],"mesh":[{"descriptor_ui":"D001157","descriptor_name":"Arterial Occlusive Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011457","descriptor_name":"Prostaglandins D","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017482","descriptor_name":"Receptors, Thromboxane","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/01.cir.73.2.240","doi":"https://doi.org/10.1161/01.cir.73.2.240","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.cir.73.2.240","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.73.2.240","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:2935325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2935325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1161/01.cir.73.2.240","doi":"https://doi.org/10.1161/01.cir.73.2.240","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.cir.73.2.240","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.73.2.240","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2019277993.pdf","grobid_xml":"https://content.openalex.org/works/W2019277993.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1967999463","https://openalex.org/W1978285417","https://openalex.org/W1980581864","https://openalex.org/W1980615558","https://openalex.org/W1981159906","https://openalex.org/W1984643311","https://openalex.org/W2004189265","https://openalex.org/W2007786815","https://openalex.org/W2029039190","https://openalex.org/W2035371116","https://openalex.org/W2036888140","https://openalex.org/W2055075682","https://openalex.org/W2058994566","https://openalex.org/W2063125910","https://openalex.org/W2078745461","https://openalex.org/W2080949602","https://openalex.org/W2090940193","https://openalex.org/W2095070822","https://openalex.org/W2100858861","https://openalex.org/W2108730399","https://openalex.org/W2119518368","https://openalex.org/W2123520002","https://openalex.org/W2125389594","https://openalex.org/W2316102942","https://openalex.org/W2338414925","https://openalex.org/W2400898866","https://openalex.org/W2410145208","https://openalex.org/W2497973903","https://openalex.org/W4206501135","https://openalex.org/W4252376983"],"related_works":["https://openalex.org/W2043304436","https://openalex.org/W4302608059","https://openalex.org/W1965043589","https://openalex.org/W4240360085","https://openalex.org/W2256263855","https://openalex.org/W4298407227","https://openalex.org/W2135513316","https://openalex.org/W2609801111","https://openalex.org/W2170344519","https://openalex.org/W2032373387"],"abstract_inverted_index":{"There":[0],"is":[1,5,31],"evidence":[2],"that":[3,33,47],"aspirin":[4],"partially":[6],"effective":[7],"in":[8,39],"the":[9,25,41,49],"prophylaxis":[10],"of":[11,28,43,45],"various":[12],"vasoocclusive":[13],"disorders.":[14],"This":[15],"article":[16],"reviews":[17],"pharmacologic":[18],"opportunities":[19],"for":[20],"improvement":[21],"over":[22],"and":[23],"above":[24],"therapeutic":[26],"effect":[27],"aspirin.":[29],"It":[30],"concluded":[32],"several":[34],"rational":[35],"possibilities":[36],"merit":[37],"consideration,":[38],"particular,":[40],"use":[42],"combinations":[44],"drugs":[46],"affect":[48],"thrombotic":[50],"process":[51],"at":[52],"different":[53],"points.":[54],"Such":[55],"strategies":[56],"will":[57],"ultimately":[58],"require":[59],"validation":[60],"by":[61],"clinical":[62],"trial.":[63]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}